IPO Trending
AMANTAEQ / NSE, BSEListed

Amanta Healthcare Limited

Amanta Healthcare Limited, founded in December 1994, is a pharmaceutical company engaged in developing, manufacturing, and marketing sterile liquid products, mainly parenteral formulations, using advanced Aseptic Blow-Fill-Seal and Injection Stretch Blow Moulding technologies. The company also produces medical devices and offers a wide range of products including IV fluids, diluents, ophthalmic solutions, respiratory care products, irrigation solutions, first-aid items, and eye lubricants. Its business is divided into three units: national sales, international sales, and product partnerships with Indian and global pharmaceutical companies. Amanta manufactures over 45 generic products, distributed across India through 320 distributors and stockists, while also exporting to Africa, Latin America, the UK, and other regions. Its products are registered in 19 countries, and in Fiscal 2025, it exported branded products to 21 countries. As of March 31, 2025, the company employed 1,718 people across its formulation, development, and quality laboratories.

₹120 - ₹12682.61x sub
Listed Price135.00
Listing Gain+7.14%
Review-Analyst Consensus Verdict

May apply

Capital Market recommendation is May apply.

Apply
114%
May Apply
343%
Neutral
00%
Avoid
114%
Not Rated
229%
Brokers / Analysts Review
ReviewerRecommendationReport
Invest4Edu Private LimitedApplyDownload
Scoop InvestmentMay ApplyDownload
Exencial Research PartnersMay ApplyDownload
Minerva Capital Research SolutionsMay ApplyDownload
SNM Value Educator Research Services LLPNot RatedDownload
Capital MarketAvoidDownload
Dolat Analysis and ResearchNot RatedDownload
Capital Market Rating
ReviewerRating ScoreRating
Capital Market39.00Avoid